49
2
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TP1736L |
Fibrinogen-Binding Peptide fb-acetate
Fibrinogen-Binding Peptide (137235-80-4 fb-acetate) |
Others | Others |
Fibrinogen-Binding Peptide 137235-80-4(fb-acetate) 是纤维蛋白原受体上玻连蛋白结合位点的推定肽模拟物。它结合纤维蛋白原并抑制血小板与纤维蛋白原的粘附和血小板聚集,还抑制血小板与玻连蛋白的粘附 | |||
TP1736 |
Fibrinogen-Binding Peptide
|
||
Fibrinogen-Binding Peptide (designed by anticomplementarity hypothesis) is a presumptive peptide mimic of the vitronectin binding site on the fibrinogen receptor. Fibrinogen, a soluble plasma protein, is a cofactor in platelet activation. It is converted | |||
TP1778 |
Fibrinogen Binding Inhibitor Peptide
|
||
Fibrinogen Binding Inhibitor Peptide, a synthetic dodecapeptide, represents the specific platelet receptor recognition site of the human fibrinogen g-chain (residues 400-411). | |||
T78367 |
Fibrinogen (Bovine)
|
||
Fibrinogen (Bovine)为特异性蛋白质水解酶,通过凝血酶激活过程组装成纤维蛋白凝块。 | |||
T80683 |
γ-Fibrinogen 377-395
|
||
γ-Fibrinogen377-395是一种衍自纤维蛋白原的抑制性肽段,也被认为是纤维蛋白原的表位之一。它能在体外抑制小胶质细胞的激活并阻断纤维蛋白与Mac-1的交互作用;此外,在小鼠体内能够抑制实验性自身免疫性脑脊髓炎(EAE)的发展。因此,γ-Fibrinogen377-395对于多发性硬化症(MS)以及其他与血脑屏障损伤和小胶质细胞活化相关的神经炎症性疾病的研究具有潜在的应用价值。 | |||
T80682 |
γ-Fibrinogen 377-395 TFA
|
||
γ-Fibrinogen377-395 TFA 是纤维蛋白原衍生抑制肽,具有纤维蛋白原表位特性。该化合物能在体外抑制小胶质细胞激活、阻断纤维蛋白与Mac-1相互作用,并在小鼠体内抑制实验性自身免疫性脑脊髓炎(EAE)。该肽适用于多发性硬化症(MS)及其他血脑屏障损伤和小胶质细胞激活相关的神经炎症疾病研究。 | |||
TP1060 |
GPRP acetate (67869-62-9 free base)
Pefabloc FG,Pefa 6003,GPRP acetate |
Others | Others |
GPRP acetate (Pefabloc FG) 是纤维蛋白聚合抑制剂,可抑制纤维蛋白原与血小板膜糖蛋白 Ⅱb/IIIa 复合物(糖蛋白 IIb/IIIa 受体)之间的相互作用。 | |||
T40711 |
H-D-Phe-Pip-Arg-pNA dihydrochloride
S-2238 dihydrochloride,H-D-Phe-Pip-Arg-pNA dihydrochloride |
Others | Others |
H-D-Phe-Pip-Arg-pNA dihydrochloride (S-2238 dihydrochloride), a chromogenic substrate, mimics the N-terminal fragment of the A alpha chain of fibrinogen, the native substrate of thrombin. Specifically designed for thrombin detection, H-D-Phe-Pip-Arg-pNA dihydrochloride is employed for the quantification of antithrombin-heparin cofactor (AT-III). The AT-III assay utilizing this substrate is characterized by its sensitivity, accuracy, and ease of implementation. | |||
T12857 |
SC-52012
|
Others | Others |
SC-52012 是一种新型有效的纤维蛋白原受体 (fibrinogen receptor) 拮抗剂,是一种 RGD 模拟物,对血小板聚集有抑制作用。 | |||
T3638 |
Leukadherin-1
|
Integrin; Complement System | Cytoskeletal Signaling; Immunology/Inflammation |
Leukadherin-1 是 CD11b/CD18 的变构激活剂,可增加 CD11b/CD18 依赖性细胞对纤维蛋白原的粘附,减少白细胞运动和跨内皮迁移,具有抗炎作用。 | |||
TP1143L |
Fibrinopeptide A, human acetate
Fibrinopeptide A, human acetate(25422-31-5 free base),Human fibrinopeptide A acetate |
Others | Others |
Fibrinopeptide A, human acetate (Human fibrinopeptide A acetate)(25422-31-5 free base) 是一种 16 个残基的短多肽,由凝血酶从纤维蛋白原上切割下来。纤维蛋白肽 A (FPA) 由纤维蛋白原蛋白的 N 末端 Aα 区域在被凝血酶切割后产生。 | |||
T5519 |
Bivalirudin
BG-8967,比伐卢定,Hirulog-1 |
Thrombin | Proteases/Proteasome |
Bivalirudin (BG-8967) 是一种直接凝血酶(thrombin)抑制剂,是一种肽类抗凝剂,可在侵入性心脏病,特别是在经皮冠状动脉介入中用于抗凝。 | |||
TP1458L |
Arg-Gly-Glu-Ser acetate(93674-97-6 free base)
|
Others | Others |
Arg-Gly-Glu-Ser acetate(93674-97-6 free base) 是一种 RGD 相关肽,可控制纤维蛋白原与活化血小板结合的 RGDS 活性。 | |||
T0182L |
Clopidogrel hydrogen sulfate
硫酸氢氯吡格雷,(S)-(+)-Clopidogrel hydrogen sulfate,(S)-(+)-Clopidogrel bisulfate,SR-25990C,Clopidogrel,硫酸氯吡格雷 |
P450; P2Y Receptor | GPCR/G Protein; Metabolism; Neuroscience |
Clopidogrel hydrogen sulfate ((S)-(+)-Clopidogrel bisulfate) 是一种抗血小板药物,可防止血栓形成。它抑制 CYP2B6和 CYP2C19,IC50分别为 18.2 和 524 nM。 它是一种选择性的高亲和力 P2Y12 受体拮抗剂,可抑制纤维蛋白原与血小板的结合以及血小板的粘附和聚集。 | |||
TP1447L1 |
Arg-Gly-Asp-Cys acetate
Arg-Gly-Asp-Cys acetate(109292-46-8 free base),RGDC acetate |
Others | Others |
Arg-Gly-Asp-Cys acetate 抑制血小板聚集和纤维蛋白原结合。 Arg-Gly-Asp-Cys acetate 是纤连蛋白与细胞粘附分子的结合基序。 | |||
T26629 |
Angstrom6
A-6,A 6 peptide,A6,A 6,A6 peptide,A-6 peptide |
PAI-1 | Metabolism |
Angstrom6 (A-6 peptide) 是一种从单链尿激酶纤溶酶原激活剂(scuPA)中提取的 8 肽,它能干扰 uPA/uPAR 级联反应并抑制下游效应。Angstrom6 具有抗肿瘤活性,能通过与 CD44 结合并调节 CD44 介导的细胞信号传导,抑制肿瘤细胞的迁移、侵袭和转移。 | |||
T24347 |
L 703014
L 703,014,L-703014,L703,014,L-703,014,L703014 |
||
L 703014 is an antagonist of the fibrinogen receptor. | |||
T24290 |
L 366763
L366,763,L-366,763,L-366763,L366763,L 366,763 |
||
L 366763 is an antagonist of the peptidyl fibrinogen receptor. | |||
T25460 |
GR 83895
GR-83895,GR83895 |
||
GR 83895 is an antagonist of prototype fibrinogen receptor. | |||
T24363 |
L 767679
L-767679,L767679 |
||
L 767679 is an antagonist of the fibrinogen receptors. | |||
T24352 |
L 734217
L-734,217,L-734217,L734217,L734,217,L 734,217 |
||
L 734217 is an antagonist of the fibrinogen receptor. | |||
T25608 |
Lamifiban trifluoroacetate
Lamifiban trifluoroacetate salt |
||
Lamifiban trifluoroacetate is an antagonist of the nonpeptide platelet fibrinogen receptor (GPIIb/IIIa). | |||
T27419 |
GPRP
Gly-Pro-Arg-Pro Acetate,Gly-Pro-Arg-Pro Acetate salt |
||
Gly-Pro-Arg-Pro Acetate, an inhibitor of fibrinogen aggregation, acts by binding to fibrinopeptide A. | |||
TP1162 |
Fibrinopeptide B, human TFA (36204-23-6 free base)
FPB,human TFA,Fibrinopeptide B, human TFA |
||
FibrinopeptideB,human is a 14-amino acid polypeptide released from the amino terminus of the fibrinogen segment. | |||
T24743 |
RU-505
RU 505,RU505 |
||
RU-505 is an interaction inhibitor of Aβ-fibrinogen that acts by rescuing altered thrombosis and cognitive decline in Alzheimer's disease mice. | |||
TP1142 |
Fibrinopeptide A, human TFA
Human fibrinopeptide A TFA |
||
Fibrinopeptide A, human is a 16-residue short polypeptide cleaved from fibrinogen by thrombin. Fibrinopeptide A, human locates at the NH2-termini of the Aα chain.The conversion of monomeric fibrinogen into polymeric fibrin is mediated by thrombin, which b | |||
T22807 |
GR 144053 trihydrochloride
|
Others | Others |
platelet fibrinogen receptor glycoprotein IIb/IIIa (GpIIb/IIIa) antagonist | |||
T24353 |
L 738167
L-738167,L738167 |
||
L 738167 is a potent antagonist of the long-acting fibrinogen receptor. | |||
TP1163 |
Fibrinopeptide B, human
FPB,human |
||
Fibrinopeptide B (FPB) is produced during the cleavage of fibrinogen, by thrombin, to fibrin monomer. | |||
TP1143 |
Fibrinopeptide A, human
Human fibrinopeptide A |
||
Fibrinopeptide A, human is a 16-residue short polypeptide cleaved from fibrinogen by thrombin. Fibrinopeptide A (FPA) is produced from the N-terminal Aα region of fibrinogen protein, on cleavage by thrombin. | |||
TP1447 |
Arg-Gly-Asp-Cys
RGDC |
||
Arg-Gly-Asp-Cys is the binding motif of fibronectin and cell adhesion molecules, which can inhibit platelet aggregation and fibrinogen binding. | |||
TP1801 |
pGlu-Pro-Arg-MNA monoacetate
|
||
pGlu-Pro-Arg-MNA monoacetate is a thrombin substrate which has been modeled after a thrombin cleavage site in human fibrinogen, can be used for a sensitive assay of antithrombin III activity. | |||
T82063 |
Integrin signaling inhibitor, mP13
|
||
Integrinsignaling inhibitor, mP13 是抑制整合素信号传导,阻止内向外和外向内信号传递,涉及纤维蛋白原结合、血小板粘附及凝块收缩的化合物。 | |||
T39655 |
Arg-Gly-Asp-Cys TFA
|
||
Arg-Gly-Asp-Cys TFA serves as the binding motif through which fibronectin interacts with cell adhesion molecules. This compound has the ability to hinder platelet aggregation and fibrinogen binding. | |||
TP1864 |
[Glu1]-Fibrinopeptide B
[Glu1]-纤维蛋白肽B |
||
[Glu1]-Fibrinopeptide B, a derivative of fibrinopeptide B amino acid residues 1-14, originates from human fibrinopeptide B (hFpB). hFpB is a proteolytic cleavage product of the fibrinogen B beta-chain, specifically generated by thrombin, which plays a significant role in activating neutrophils (PMN), monocytes, and fibroblasts. | |||
TP1458 |
Arg-Gly-Glu-Ser
|
||
Arg-Gly-Glu-Ser is a RGD related peptide that is a control for the RGDS activity of fibrinogen binding to activated platelets. | |||
T39066 |
H-D-Phe-Pip-Arg-pNA hydrochloride
S-2238 hydrochloride,H-D-Phe-Pip-Arg-pNA hydrochloride |
||
H-D-Phe-Pip-Arg-pNA hydrochloride, a chromogenic substrate, mimics the N-terminal segment of the A alpha chain of fibrinogen, the native substrate of thrombin. It displays specificity towards thrombin and is employed for quantifying antithrombin-heparin cofactor (AT-III). The utilization of H-D-Phe-Pip-Arg-pNA hydrochloride in the AT-III assay enables a sensitive, accurate, and straightforward measurement process. | |||
TP1355 |
Arg-Gly-Glu-Ser(TFA)(93674-97-6,free)
Arg-Gly-Glu-Ser(TFA) |
||
Arg-gly-glu -Ser(TFA) is a RGD related polypeptide that controls the inhibition of fibrinogen binding to activated platelets by RGDS. | |||
T35582 |
H-Arg-Gly-Asp-Cys-OH (trifluoroacetate salt)
|
||
H-Arg-Gly-Asp-Cys-OH is a tetrapeptide that contains the arginine-glycine-aspartate (RGD) motif, a sequence that acts as a recognition site for various adhesion proteins.1It inhibits the binding of fibrinogen to endothelial cells and ADP-stimulated platelets with IC50values of 320 and 35 μM, respectively.2Implantation of titanium rods coated with H-Arg-Gly-Asp-Cys-OH increases bone formation in rat femurs.3H-Arg-Gly-Asp-Cys-OH has been conjugated to polyethylenimine to improve gene transfection ... | |||
T81985 |
K-Casein (106-116),bovine
|
||
K-Casein (106-116), bovine,为一抗血小板聚集与纤维蛋白原结合的多肽,动脉粥样硬化关键作用因子。 | |||
T76376 |
Lys-Gln-Ala-Gly-Asp-Val
|
||
Lys-Gln-Ala-Gly-Asp-Val (KQAGDV), 纤维蛋白原γ链(fibrinogen γ-chain)末端六个氨基酸组成,是细胞粘附肽。通过α2bβ3整合素,介导细胞粘附,对平滑肌细胞(SMCs)具有有效粘附配体功能。 | |||
T78001 |
Arg-Gly-Glu-Ser TFA
|
||
Arg-Gly-Glu-Ser TFA,作为RGD相关多肽,调节RGDS对纤维蛋白原及活化血小板结合的抑制作用。 | |||
T38542 |
H-D-Phe-Pip-Arg-pNA acetate
H-D-Phe-Pip-Arg-pNA acetate,S-2238 acetate |
||
H-D-Phe-Pip-Arg-pNA (S-2238) acetate is a chromogenic substrate designed based on the N-terminal fragment of the A alpha chain of fibrinogen, which is the physiological target of thrombin. As a specific indicator of thrombin activity, H-D-Phe-Pip-Arg-pNA acetate is utilized to quantify. This assay, utilizing H-D-Phe-Pip-Arg-pNA acetate, ensures high sensitivity, accuracy, and ease of execution. | |||
T64287 |
Reteplase
|
||
Reteplase (BM 06.022) 是一种重组纤溶酶原 (plasminogen) 激活剂,由人组织型纤溶酶原激活剂的 kringle 2 和蛋白酶结构域构成。Reteplase 能够将纤溶酶原转化为纤溶酶,促使血栓溶解。Reteplase 通过 DNA 技术在大肠杆菌中产生的 t-PA 突变体,未糖基化。 | |||
T62731 |
ZK824190 hydrochloride
|
||
ZK824190 hydrochloride 是一种选择性的、口服具有活力的尿激酶型纤溶酶原激活剂 (uPA) 抑制剂,能够作用于 uPA (IC50: 237 nM)、tPA (IC50: 1600 nM) 和 Plasmin (IC50: 1850 nM)。ZK824190 hydrochloride 能够用于研究多发性硬化症的研究 | |||
T62961 | ZK824859 hydrochloride | ||
ZK824859 hydrochloride 是一种选择性的、口服具有活力的尿激酶型纤溶酶原激活剂 (uPA) 抑制剂。ZK824859 hydrochloride 对人 uPA,tPA 和纤溶酶的 IC50 值分别为 79 nM,1580 nM 和 1330 nM。 | |||
T74840 | ERRγ agonist-2 | ||
ERRγagonist-2 是一种有效的选择性 ERRγ反向激动剂,Kd 值为 6.5 μM。ERRγagonist-2 抑制铁调素、纤维蛋白原和糖异生基因的表达。ERRγagonist-2 具有抗菌、抗凝血和抗糖尿病活性。 | |||
TP2234 |
coagulation factor II (thrombin) B chain fragment [Homo sapiens]
|
Others | Others |
Thrombin is a "trypsin-like" serine protease that is encoded by the F2 gene in humans. Thrombin is produced by the enzymatic cleavage of two sites on prothrombin by activated Factor X (Xa). Thrombin in turn acts as a serine protease that converts soluble | |||
T83736 |
RTDLDSLRTYTL TFA
|
||
RTDLDSLRTYTL是一种αVβ6整合素配体。它选择性地抑制纤维连接蛋白与αVβ6整合素的结合,相比之下,对于纤维连接蛋白与αVβ3或αVβ5以及纤维蛋白原与αIIβ3的结合则几乎不产生影响(IC50分别为0.02, >50, >50, 和 >50 µM)。此外,RTDLDSLRTYTL还能以浓度依赖的方式抑制HT-29结肠癌细胞与纤维连接蛋白的结合。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T3793 |
(20R)-Ginsenoside Rh1
20(R)-Ginsenoside Rh1,人参皂苷 R-RH1,人参皂苷R-RH1 |
Others | Others |
(20R)-Ginsenoside Rh1 (20(R)-Ginsenoside Rh1) 是 Ginsenoside Rh1 的 R 型异构体,分离自 Panax Ginseng 中,能够阻碍凝血酶诱导的纤维蛋白原向纤维蛋白的转化。 | |||
TN5221 | (-)-Variabilin | ||
Variabilin, a novel inhibitor of human platelet aggregation, it is a potent RGD (Arg-Gly-Asp)-containing antagonist of the fibrinogen receptor glycoprotein IIb-IIIa (GPIIb-IIIa; αIIbβ3) and the vitronectin receptor αvβ3.Variabilin is also an antimicrobial furanosesterterpene. Variabilin is an inhibitor of human secretory and cytosolic phospholipase A2 (PLA2) activities that controls eicosanoid production in vitro and in vivo, inhibits neutrophil degranulation and superoxide generation in vitro a... |